Decibel Therapeutics Inc is a biotechnology business based in the US. Decibel Therapeutics Inc shares (DBTX) are listed on the NASDAQ and all prices are listed in US Dollars. Decibel Therapeutics Inc employs 68 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Decibel Therapeutics stock
How to buy Decibel Therapeutics Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DBTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Decibel Therapeutics Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Decibel Therapeutics Inc stock price (NASDAQ: DBTX)
Use our graph to track the performance of DBTX stocks over time.Decibel Therapeutics Inc shares at a glance
Latest market close | $4.91 |
---|---|
52-week range | $4.88 - $5.21 |
50-day moving average | $4.61 |
200-day moving average | $3.77 |
Wall St. target price | $10.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.54 |
Is it a good time to buy Decibel Therapeutics Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Decibel Therapeutics Inc price performance over time
Historical closes compared with the close of $4.91 from 2023-10-04
1 week (2024-08-27) | N/A |
---|---|
1 month (2024-08-03) | N/A |
3 months (2024-06-03) | N/A |
6 months (2024-03-03) | N/A |
1 year (2023-09-07) | -4.10% |
---|---|
2 years (2022-09-07) | -4.47% |
3 years (2021-09-07) | 8.15 |
5 years (2019-09-03) | N/A |
Decibel Therapeutics Inc financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -32.65% |
Return on equity TTM | -76.76% |
Profit margin | 0% |
Book value | $2.12 |
Market Capitalization | $123.4 million |
TTM: trailing 12 months
Decibel Therapeutics Inc share dividends
We're not expecting Decibel Therapeutics Inc to pay a dividend over the next 12 months.
Decibel Therapeutics Inc share price volatility
Over the last 12 months, Decibel Therapeutics Inc's shares have ranged in value from as little as $4.88 up to $5.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Decibel Therapeutics Inc's is -0.4025. This would suggest that Decibel Therapeutics Inc's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Decibel Therapeutics Inc has bucked the trend.
To put Decibel Therapeutics Inc's beta into context you can compare it against those of similar companies.
- Idera Pharmaceuticals (IDRA.US): 1.2979
- Leap Therapeutics (LPTX.US): 0.281
Decibel Therapeutics Inc overview
Decibel Therapeutics, Inc. , a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. The company's product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. Its lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. The company is also developing DB-ATO and AAV. 201, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule; DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial; AAV. 103 to restore hearing in individuals with a gap junction beta-2 (GJB2) deficiency; AAV.
Frequently asked questions
nullWhat percentage of Decibel Therapeutics Inc is owned by insiders or institutions?
Currently 13.355% of Decibel Therapeutics Inc shares are held by insiders and 61.95% by institutions. How many people work for Decibel Therapeutics Inc?
Latest data suggests 68 work at Decibel Therapeutics Inc. When does the fiscal year end for Decibel Therapeutics Inc?
Decibel Therapeutics Inc's fiscal year ends in December. Where is Decibel Therapeutics Inc based?
Decibel Therapeutics Inc's address is: 1325 Boylston Street, Boston, MA, United States, 02215 What is Decibel Therapeutics Inc's ISIN number?
Decibel Therapeutics Inc's international securities identification number is: US24343R1068
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
7 best day trading platforms of 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Trading for beginners: 11 best trading platforms to get started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 best international stock brokers to invest in foreign assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 best discount brokers of 2024 for low-cost trading and investing
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 best stock apps of 2024 to elevate your mobile trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question